Literature DB >> 29174306

Sex and gender differences in substance use disorders.

R Kathryn McHugh1, Victoria R Votaw2, Dawn E Sugarman3, Shelly F Greenfield3.   

Abstract

The gender gap in substance use disorders (SUDs), characterized by greater prevalence in men, is narrowing, highlighting the importance of understanding sex and gender differences in SUD etiology and maintenance. In this critical review, we provide an overview of sex/gender differences in the biology, epidemiology and treatment of SUDs. Biological sex differences are evident across an array of systems, including brain structure and function, endocrine function, and metabolic function. Gender (i.e., environmentally and socioculturally defined roles for men and women) also contributes to the initiation and course of substance use and SUDs. Adverse medical, psychiatric, and functional consequences associated with SUDs are often more severe in women. However, men and women do not substantively differ with respect to SUD treatment outcomes. Although several trends are beginning to emerge in the literature, findings on sex and gender differences in SUDs are complicated by the interacting contributions of biological and environmental factors. Future research is needed to further elucidate sex and gender differences, especially focusing on hormonal factors in SUD course and treatment outcomes; research translating findings between animal and human models; and gender differences in understudied populations, such as those with co-occurring psychiatric disorders and gender-specific populations, such as pregnant women.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Female; Gender differences; Risk factors; Substance use disorders; Treatment outcomes; Women

Mesh:

Year:  2017        PMID: 29174306      PMCID: PMC5945349          DOI: 10.1016/j.cpr.2017.10.012

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  196 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  Characteristics and correlates of quitting among black and white low-income pregnant smokers.

Authors:  Kenneth D Ward; Mark W Vander Weg; Marie A Sell; Isabel C Scarinci; Mary Cocke Read
Journal:  Am J Health Behav       Date:  2006 Nov-Dec

3.  Financial incentives for smoking cessation in pregnancy: randomised controlled trial.

Authors:  David Tappin; Linda Bauld; David Purves; Kathleen Boyd; Lesley Sinclair; Susan MacAskill; Jennifer McKell; Brenda Friel; Alex McConnachie; Linda de Caestecker; Carol Tannahill; Andrew Radley; Tim Coleman
Journal:  BMJ       Date:  2015-01-27

4.  The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014.

Authors:  Hannah Carliner; Pia M Mauro; Qiana L Brown; Dvora Shmulewitz; Reanne Rahim-Juwel; Aaron L Sarvet; Melanie M Wall; Silvia S Martins; Geoffrey Carliner; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2016-11-11       Impact factor: 4.492

5.  Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence.

Authors:  Marc N Potenza; Kwang-ik Adam Hong; Cheryl M Lacadie; Robert K Fulbright; Keri L Tuit; Rajita Sinha
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

6.  Female sex and oral contraceptive use accelerate nicotine metabolism.

Authors:  Neal L Benowitz; Christina N Lessov-Schlaggar; Gary E Swan; Peyton Jacob
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

7.  Influence of gender and race/ethnicity on perceived barriers to help-seeking for alcohol or drug problems.

Authors:  Angie Denisse Otiniano Verissimo; Christine E Grella
Journal:  J Subst Abuse Treat       Date:  2017-01-25

8.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.

Authors:  Carlos A Hernandez-Avila; Bruce J Rounsaville; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

9.  Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.

Authors:  Sherry A McKee; Philip H Smith; Mira Kaufman; Carolyn M Mazure; Andrea H Weinberger
Journal:  Nicotine Tob Res       Date:  2015-10-06       Impact factor: 4.244

10.  Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Authors:  Sharaf S Khan; Roberto Secades-Villa; Mayumi Okuda; Shuai Wang; Gabriela Pérez-Fuentes; Bradley T Kerridge; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-11-22       Impact factor: 4.492

View more
  130 in total

1.  Religious service attendance typologies and African American substance use: a longitudinal study of the protective effects among young adult men and women.

Authors:  David R Hodge; Shiyou Wu; Qi Wu; Flavio F Marsiglia; Weitao Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-02-06       Impact factor: 4.328

2.  Difficulties Regulating Positive Emotions and Substance Misuse: The Influence of Sociodemographic Factors.

Authors:  Melissa R Schick; Nicole H Weiss; Ateka C Contractor; Emmanuel D Thomas; Nichea S Spillane
Journal:  Subst Use Misuse       Date:  2020-02-20       Impact factor: 2.164

Review 3.  Addictive behaviors across the menstrual cycle: a systematic review.

Authors:  Kayla M Joyce; Kimberley P Good; Philip Tibbo; Jocelyn Brown; Sherry H Stewart
Journal:  Arch Womens Ment Health       Date:  2021-01-06       Impact factor: 3.633

Review 4.  Comorbidity of opioid-related and anxiety-related symptoms and disorders.

Authors:  Kirsten J Langdon; Kathrine Dove; Susan Ramsey
Journal:  Curr Opin Psychol       Date:  2019-01-04

5.  Women and substance use disorders in low- and middle-income countries: A call for advancing research equity in prevention and treatment.

Authors:  Ilze Slabbert; M Claire Greene; Jacqueline S Womersley; Oladiran I Olateju; Matiwos Soboka; Andrine M Lemieux
Journal:  Subst Abus       Date:  2019-11-07       Impact factor: 3.716

6.  Prevalence of 12-month mental and substance use disorders in sexual minority college students in Mexico.

Authors:  Roberto Rentería; Corina Benjet; Raúl A Gutiérrez-García; Adrián Abrego-Ramírez; Yesica Albor; Guilherme Borges; María Anabell Covarrubias Díaz-Couder; María Del Socorro Durán; Rogaciano González-González; Rebeca Guzmán Saldaña; Alicia E Hermosillo De la Torre; Ana María Martínez-Jerez; Kalina I Martinez Martinez; María Elena Medina-Mora; Sinead Martínez Ruiz; María Abigail Paz Pérez; Gustavo Pérez Tarango; María Alicia Zavala Berbena; Enrique Méndez; Randy P Auerbach; Philippe Mortier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-09-04       Impact factor: 4.328

7.  Medicaid Utilization Before and After a Natural Disaster in the 2016 Baton Rouge-Area Flood.

Authors:  Stephen W Phillippi; Kaylin Beiter; Casey L Thomas; Olivia K Sugarman; Ashley Wennerstrom; Kenneth B Wells; Edward Trapido
Journal:  Am J Public Health       Date:  2019-09       Impact factor: 9.308

Review 8.  Exploring African-American womens' experiences with substance use treatment: A review of the literature.

Authors:  Michelle L Redmond; Sharla Smith; Tracie C Collins
Journal:  J Community Psychol       Date:  2019-10-14

9.  Association between History of Concussion and Substance Use Is Mediated by Mood Disorders.

Authors:  Sharlene D Newman; Jesse G Grantz; Kelsie Brooks; Arianna Gutierrez; Keisuke Kawata
Journal:  J Neurotrauma       Date:  2019-09-18       Impact factor: 5.269

10.  Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems.

Authors:  Adam T Hirsh; Tracy M Anastas; Megan M Miller; Patrick D Quinn; Kurt Kroenke
Journal:  Am Psychol       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.